Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

U.S. News

Life Insurance Ban on HIV/AIDS Patients Unjustified Due to Advent of Antiretroviral Therapy, Study Says

September 12, 2003

Life insurance companies' ban on providing coverage for people with HIV/AIDS is in many cases unjustified, according to a study published in the Sept. 13 issue of the Lancet, BBC News reports (BBC News, 9/12). Because of high death rates among AIDS patients in the past and a perception that mortality among HIV-positive patients is much higher than in the general population, HIV/AIDS patients are unable to obtain life insurance in major European countries and the United States (Jaggy et al., Lancet, 9/13). However, the Swiss researchers who conducted the study said that the automatic ban on HIV-positive people does not take into account the success of antiretroviral treatment, Agence France-Presse reports (Agence France-Presse, 9/11). The researchers from 1997 to 2001 measured mortality rates in 3,963 people enrolled in the Swiss HIV Cohort Study, an ongoing study of HIV-positive people in seven large hospitals throughout Switzerland. The researchers compared death rates of the HIV-positive people in the study to the death rates of the overall Swiss population (Lancet, 9/13). Dr. Bernard Hirschel of the Geneva University Hospital, a co-author of the study, said, "Successfully treated HIV-positive and hepatitis C negative patients have a short-term mortality as low as, or lower than that of, patients with cancer who have been successfully treated -- a group that is able to obtain life insurance" (BBC News, 9/12). The researchers defined successful treatment as having a CD4+ T cell count greater than 250 cells/mm3 at least six months after starting treatment. They predicted that the mortality rate among these patients is likely to remain low over the next several years (Lancet, 9/11). However, short-term mortality was significantly higher among HIV-positive patients who had failed to respond to HAART or who had hepatitis C. The researchers concluded that the study "provides preliminary evidence that life coverage could be considered under specific conditions" (Agence France-Presse, 9/11).

Back to other news for September 12, 2003


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2003 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More on Life Insurance and HIV/AIDS
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

Tools
 

Advertisement